ALBO
Vanguard Group’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-948,532
| Closed | -$20.5M | – | 4614 |
|
2022
Q4 | $20.5M | Buy |
948,532
+31,052
| +3% | +$671K | ﹤0.01% | 2617 |
|
2022
Q3 | $17.8M | Sell |
917,480
-76,490
| -8% | -$1.48M | ﹤0.01% | 2681 |
|
2022
Q2 | $19.7M | Buy |
993,970
+16,305
| +2% | +$324K | ﹤0.01% | 2649 |
|
2022
Q1 | $29.2M | Buy |
977,665
+42,235
| +5% | +$1.26M | ﹤0.01% | 2575 |
|
2021
Q4 | $21.8M | Sell |
935,430
-15,976
| -2% | -$372K | ﹤0.01% | 2793 |
|
2021
Q3 | $29.7M | Buy |
951,406
+27,009
| +3% | +$843K | ﹤0.01% | 2647 |
|
2021
Q2 | $32.5M | Buy |
924,397
+17,672
| +2% | +$622K | ﹤0.01% | 2589 |
|
2021
Q1 | $32M | Buy |
906,725
+20,925
| +2% | +$738K | ﹤0.01% | 2554 |
|
2020
Q4 | $33.2M | Buy |
885,800
+599,177
| +209% | +$22.5M | ﹤0.01% | 2400 |
|
2020
Q3 | $9.57M | Buy |
286,623
+36,572
| +15% | +$1.22M | ﹤0.01% | 2811 |
|
2020
Q2 | $6.62M | Buy |
250,051
+15,107
| +6% | +$400K | ﹤0.01% | 2965 |
|
2020
Q1 | $3.85M | Buy |
234,944
+21,007
| +10% | +$344K | ﹤0.01% | 3080 |
|
2019
Q4 | $5.44M | Buy |
213,937
+7,123
| +3% | +$181K | ﹤0.01% | 3143 |
|
2019
Q3 | $4.14M | Buy |
206,814
+29,167
| +16% | +$583K | ﹤0.01% | 3204 |
|
2019
Q2 | $5.73M | Buy |
177,647
+16,236
| +10% | +$523K | ﹤0.01% | 3120 |
|
2019
Q1 | $5.2M | Buy |
161,411
+4,179
| +3% | +$135K | ﹤0.01% | 3133 |
|
2018
Q4 | $3.86M | Buy |
157,232
+30,226
| +24% | +$741K | ﹤0.01% | 3167 |
|
2018
Q3 | $4.19M | Buy |
127,006
+1,109
| +0.9% | +$36.6K | ﹤0.01% | 3299 |
|
2018
Q2 | $4.47M | Buy |
125,897
+32,616
| +35% | +$1.16M | ﹤0.01% | 3247 |
|
2018
Q1 | $3.04M | Buy |
93,281
+62,262
| +201% | +$2.03M | ﹤0.01% | 3321 |
|
2017
Q4 | $794K | Buy |
31,019
+1,056
| +4% | +$27K | ﹤0.01% | 3661 |
|
2017
Q3 | $628K | Sell |
29,963
-506
| -2% | -$10.6K | ﹤0.01% | 3697 |
|
2017
Q2 | $628K | Buy |
30,469
+600
| +2% | +$12.4K | ﹤0.01% | 3684 |
|
2017
Q1 | $717K | Buy |
29,869
+1,404
| +5% | +$33.7K | ﹤0.01% | 3672 |
|
2016
Q4 | $505K | Sell |
28,465
-1,365,620
| -98% | -$24.2M | ﹤0.01% | 3734 |
|
2016
Q3 | $602K | Sell |
1,394,085
-134,889
| -9% | -$58.2K | ﹤0.01% | 3710 |
|
2016
Q2 | $475K | Buy |
1,528,974
+73,941
| +5% | +$23K | ﹤0.01% | 3808 |
|
2016
Q1 | $480K | Buy |
1,455,033
+340,219
| +31% | +$112K | ﹤0.01% | 3798 |
|
2015
Q4 | $382K | Buy |
1,114,814
+58,024
| +5% | +$19.9K | ﹤0.01% | 3894 |
|
2015
Q3 | $465K | Buy |
1,056,790
+358,669
| +51% | +$158K | ﹤0.01% | 3868 |
|
2015
Q2 | $720K | Buy |
698,121
+133,665
| +24% | +$138K | ﹤0.01% | 3756 |
|
2015
Q1 | $672K | Buy |
564,456
+43,137
| +8% | +$51.4K | ﹤0.01% | 3744 |
|
2014
Q4 | $693K | Buy |
521,319
+8,820
| +2% | +$11.7K | ﹤0.01% | 3639 |
|
2014
Q3 | $856K | Buy |
512,499
+18,255
| +4% | +$30.5K | ﹤0.01% | 3554 |
|
2014
Q2 | $1.07M | Buy |
494,244
+9,100
| +2% | +$19.6K | ﹤0.01% | 3467 |
|
2014
Q1 | $1.33M | Buy |
485,144
+63,375
| +15% | +$173K | ﹤0.01% | 3366 |
|
2013
Q4 | $970K | Buy |
421,769
+27,900
| +7% | +$64.2K | ﹤0.01% | 3425 |
|
2013
Q3 | $1.24M | Buy |
393,869
+10,573
| +3% | +$33.3K | ﹤0.01% | 3309 |
|
2013
Q2 | $1.6M | Buy |
+383,296
| New | +$1.6M | ﹤0.01% | 3145 |
|